A Beta-only IL-2 ImmunoTherapY Study
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Cutaneous Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Imgatuzumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
IFx-Hu2.0 for the Treatment of Patients With Skin Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
IFx-Hu2.0 Expanded Access Program
- Status
- AVAILABLE
- Phase
- N/A
Neoadjuvant Atezolizumab in Surgically Resectable Advanced Cutaneous Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck
- Status
- UNKNOWN
- Phase
- NA
Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients
- Status
- WITHDRAWN
- Phase
- PHASE2
Neoadjuvant Plus Adjuvant Treatment With Cemiplimab in Cutaneaous Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Neo-adjuvant Nivolumab or Nivolumab With Ipilimumab in Advanced Cutaneous Squamous Cell Carcinoma Prior to Surgery
- Status
- COMPLETED
- Phase
- PHASE2
In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy
- Status
- TERMINATED
- Phase
- PHASE1
Ph1 Study of SL-172154 Administered Intratumorally in Subjects With Squamous Cell Carcinoma of the Head and Neck or Skin
- Status
- TERMINATED
- Phase
- PHASE1
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Study of Metabolic Changes in the Transformation Malignant Precancerous Skin Lesions
- Status
- UNKNOWN
- Phase
- NA
Cemiplimab in AlloSCT/SOT Recipients With CSCC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1